HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Disse Selected Research

serum tumorlytic factor

9/2012The tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Disse Research Topics

Disease

2Thrombosis (Thrombus)
09/2012 - 07/2011
2Neoplasm Metastasis (Metastasis)
09/2012 - 07/2011
2Neoplasms (Cancer)
09/2012 - 07/2011
1Melanoma (Melanoma, Malignant)
09/2012
1Breast Neoplasms (Breast Cancer)
09/2012
1Glioblastoma (Glioblastoma Multiforme)
09/2012
1Hypoxia (Hypoxemia)
07/2011

Drug/Important Bio-Agent (IBA)

2Thromboplastin (Tissue Factor)IBA
09/2012 - 07/2011
1Proteinase-Activated ReceptorsIBA
09/2012
1AnticoagulantsIBA
09/2012
1serum tumorlytic factorIBA
09/2012
1Peptide Hydrolases (Proteases)FDA Link
07/2011